MiGenTra GmbH
Frederic Bouvier, MSc, MBA, is a seasoned executive with extensive experience in the life sciences and pharmaceutical industries. Currently serving as General Manager and VP Corporate & Business Development at MiGenTra GmbH since 2022, Frederic has demonstrated expertise in setting strategic directions for long-term growth, managing financials, leading high-performing teams, and securing partnerships. Prior roles include Senior Director at Fresenius Kabi, where Frederic transformed an R&D platform, and Global Head of Business & Strategic Projects at Sanofi, focusing on biologics manufacturing and portfolio development. With a strong educational foundation including an MBA from Sciences Po and a Master's in Organic Chemistry from the University of Houston, Frederic has a proven track record in business development, strategic planning, and corporate governance.
This person is not in any teams
This person is not in any offices
MiGenTra GmbH
MiGenTra is a healthcare transforming medicines company, and a subsidiary of ProBioGen, with a focus on high quality medicines at affordable prices. The company allows for product development in the field of Biosimilars, Cell and Gene Therapies and vaccines especially for Egypt, the Middle East and Africa, and will therefore provide access to key healthcare transforming medicines, while strengthening regional and local manufacturing capacity in the region. MiGenTra combines scientific and manufacturing subject matter expertise from both contributing companies, ProBioGen and Minapharm Pharmaceuticals and is headquartered in Berlin, Germany and has access to a site in Cairo, Egypt, where the main manufacturing plant is located.